POPULATION AGING AND THE RISE OF REFRACTORY LEUKEMIAS: SURVEILLANCE, SCREENING AND STRATEGIC HEALTH PLANNING

Emmanuel Ifeanyi Obeagu; Aakib Rahman Parray

doi:10.22270/ujpr.v10i5.1430

Emmanuel Ifeanyi Obeagu Department of Biomedical and Laboratory Science, Africa University, Zimbabwe.
Aakib Rahman Parray Department of Psychology, Akal University, India.

10.22270/ujpr.v10i5.1430

Keywords:

health planning, population aging, refractory leukemias, surveillance, screening

Abstract

The global demographic shift towards an aging population has led to a marked increase in the incidence of refractory leukemias, posing significant challenges for healthcare systems worldwide. Older adults are disproportionately affected by leukemias that are resistant to conventional therapies, resulting in poorer prognoses and increased morbidity. This review explores the multifaceted impact of population aging on the epidemiology and management of refractory leukemias, highlighting the urgent need for tailored public health interventions. Effective surveillance systems are critical to monitoring trends in leukemia incidence, treatment resistance, and outcomes among elderly populations. Enhanced data collection and integration of molecular and clinical markers can improve early identification of high-risk individuals and inform resource allocation. Additionally, risk-based screening strategies adapted to the unique needs of older adults have the potential to facilitate earlier diagnosis and improve responsiveness to treatment, ultimately reducing the progression to refractory disease. Strategic health planning that incorporates multidisciplinary care models, public health policy initiatives, and community engagement is essential to address the complex care needs of elderly leukemia patients. Investments in healthcare infrastructure, provider training, and supportive services will improve quality of life and clinical outcomes. Collaborative efforts to integrate surveillance and screening into comprehensive health plans can help mitigate the growing public health burden of refractory leukemias in aging populations.